Forbes

Neurotech prosthetics are the first serious foray into robotics . Phantom Neuro and BIOS new clinical implantations show a side of the BCI market with broader applications.

AI-designed T-cell receptors improved cancer-cell killing in the lab and tumor control in mice, pointing toward more effective engineered T-cell therapies.

Today’s publication of the PatientView’s 2026: A Seat at the Pricing Table report is striking in how patient groups globally are trying to shape access and affordability.

GLP-1 travel is changing hotels, from medication fridges and protein menus to wellness-led itineraries. See what travelers now expect.

As Uber enters its eighth year as a healthcare provider, the ride-sharing giant says its services are more integrated into health plans and government benefits.

Dariush Mozaffarian’s Food Is Medicine challenges nutrition’s focus on what to cut, urging readers to build meals around foods that nourish.

Oscar Health plans to expand its individual health insurance coverage offerings into one new state and 140 new counties next year even as rivals exit the market.

It’s expected that 2027 will see the largest spike in recent memory of the numbers of un- and underinsured individuals in the United States.

Orexin reveals how a small brain peptide controls wakefulness, explains narcolepsy, and inspires new treatments—and a search for the genome’s hidden proteins.

The Big 12 admitted a clock error ended BYU vs. Notre Dame football game early. A neurosurgeon discusses how surgical timeouts can be applied to improve the process.

Government policies and private-market incentives reward hospital-physician consolidation and increase healthcare costs. Insurers are pushing back, but face limits.

Washington is loosening oversight of clinical AI while California and other states are writing their own rules. A physician explains what may happen next for clinical AI.

Healthcare organizations have long relied on incremental adjustments that failed to resolve the affordability crisis. New economic forces require a different strategy.

Bloomberg Philanthropies and Vision To Learn just announced a new $8.4 million investment into expanding school-based vision care for children in the U.S.

Trump has publicly slammed pharma and health insurers for their alleged profiteering off the backs of patients. But his administration’s policies have had little impact.